EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?

Caleb Kim, Lara E Davis, Catherine M Albert, Brian Samuels iD, Jesse L Roberts, Michael J Wagner iD

Cancers · 19.10.2023 · 15 (20) · 5044

DOI: 10.3390/cancers15205044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 19.10.2023. Verfasst von Caleb Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, University of Washington, Spokane, WA 99202, USA. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant bone tumors are commonly classified as pediatric or adolescent malignancies, and clinical trials for these diseases have generally focused on these populations. Of primary bone cancers, osteosarcoma is among the most common. Osteosarcoma has a bimodal age distribution, with the first peak occurring in patients from 10 to 14 years old, and the second peak occurring in patients older than 65, with about 25% of cases occurring in adults between 20 and 59 years old. Notably, adult osteosarcoma patients have worse outcomes than their pediatric counterparts. It remains unclear whether age itself is a poor prognostic factor, or if inherent differences in tumor biology exist between age groups. Despite these unknowns, current treatment strategies for adults are largely extrapolated from pediatric studies since the majority of clinical trials for osteosarcoma treatments are based on younger patient populations. In light of the different prognoses observed in pediatric and adult osteosarcoma, we summarize the current understanding of the molecular etiology of osteosarcoma and how it may differ between age groups, hypothesizing why adult patients have worse outcomes compared to children.

Schlagwörter

Stichwörter der Autor:innen

AYAadolescent/young adult oncologybone tumorsosteosarcomasarcoma

Autor:innen und Institutionen

  • Division of Hematology and Oncology, University of Washington, Spokane, WA 99202, USA.
  • Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
  • Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, Seattle Children's Hospital, Seattle, WA 98105, USA.
  • Beacon Cancer Care, Coeur d'Alene, ID 83814, USA.
  • Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA 98109, USA.
  • Division of Hematology and Oncology, University of Washington, Seattle, WA 98109, USA.

ORCID-Profile: Brian Samuels, Michael J Wagner

Zitieren

APA

Kim, C., Davis, L. E., Albert, C. M., Samuels, B., Roberts, J. L., & Wagner, M. J. (2023). Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?. Cancers, 15(20), 5044. https://doi.org/10.3390/cancers15205044

Vancouver

Kim C, Davis LE, Albert CM, Samuels B, Roberts JL, Wagner MJ. Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?. Cancers. 2023;15(20):5044. doi:10.3390/cancers15205044

BibTeX
@article{Kim2023,
  author = {Kim, Caleb and Davis, Lara E and Albert, Catherine M and Samuels, Brian and Roberts, Jesse L and Wagner, Michael J},
  title = {Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {20},
  pages = {5044},
  doi = {10.3390/cancers15205044}
}
Kostenlos starten →